Literature DB >> 27500089

Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies.

Jordan Andrews1, Rishi Puri2, Yu Kataoka3, Stephen J Nicholls1, Peter J Psaltis1.   

Abstract

Despite advances in risk prediction, preventive and therapeutic strategies, atherosclerotic cardiovascular disease remains a major public health challenge worldwide, carrying considerable morbidity, mortality and health economic burden. There continues to be a need to better understand the natural history of this disease to guide the development of more effective treatment, integral to which is the rapidly evolving field of coronary artery imaging. Various imaging modalities have been refined to enable detailed visualization of the pathological substrate of atherosclerosis, providing accurate and reproducible measures of coronary plaque burden and composition, including the presence of high-risk characteristics. The serial application of such techniques, including coronary computed tomography angiography (CTA), intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have uncovered important insights into the progression of coronary plaque over time in patients with stable and unstable coronary artery disease (CAD), and its responsiveness to therapeutic interventions. Here we review the use of different imaging modalities for the surveillance of coronary atherosclerosis and the lessons they have provided about the modulation of CAD by both traditional and experimental therapies.

Entities:  

Keywords:  Atherosclerosis; cholesterol; coronary artery disease (CAD); imaging; intravascular ultrasound (IVUS)

Year:  2016        PMID: 27500089      PMCID: PMC4960069          DOI: 10.21037/cdt.2015.10.02

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  128 in total

1.  Coronary plaque classification with intravascular ultrasound radiofrequency data analysis.

Authors:  Anuja Nair; Barry D Kuban; E Murat Tuzcu; Paul Schoenhagen; Steven E Nissen; D Geoffrey Vince
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.

Authors:  Marit Westerterp; Caroline C van der Hoogt; Willeke de Haan; Erik H Offerman; Geesje M Dallinga-Thie; J Wouter Jukema; Louis M Havekes; Patrick C N Rensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-31       Impact factor: 8.311

Review 4.  Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography.

Authors:  Veit Sandfort; Joao A C Lima; David A Bluemke
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

5.  Reproducibility of carotid atherosclerotic lesion type characterization using high resolution multicontrast weighted cardiovascular magnetic resonance.

Authors:  Baocheng Chu; Binh An P Phan; Niranjan Balu; Chun Yuan; B Greg Brown; Xue-Qiao Zhao
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

6.  Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.

Authors:  Rishi Puri; Peter Libby; Steven E Nissen; Kathy Wolski; Christie M Ballantyne; Phillip J Barter; M John Chapman; Raimund Erbel; Joel S Raichlen; Kiyoko Uno; Yu Kataoka; E Murat Tuzcu; Stephen J Nicholls
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-20       Impact factor: 6.875

7.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

8.  Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.

Authors:  B Föger; M Chase; M J Amar; B L Vaisman; R D Shamburek; B Paigen; J Fruchart-Najib; J A Paiz; C A Koch; R F Hoyt; H B Brewer; S Santamarina-Fojo
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

10.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

View more
  3 in total

1.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

Review 2.  Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.

Authors:  Adam J Nelson; Maddalena Ardissino; Peter J Psaltis
Journal:  Ther Adv Chronic Dis       Date:  2019-11-01       Impact factor: 5.091

3.  Progression of coronary atherosclerosis in patients without standard modifiable risk factors.

Authors:  Jawad Mazhar; Gemma Figtree; Stephen T Vernon; Keyvan Karimi Galougahi; Julie Carlo; Steven E Nissen; Stephen J Nicholls
Journal:  Am J Prev Cardiol       Date:  2020-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.